Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Iovance Biotherapeutics Inc (IOVA)

Iovance Biotherapeutics Inc (IOVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,480,918
  • Shares Outstanding, K 304,781
  • Annual Sales, $ 1,190 K
  • Annual Income, $ -444,040 K
  • EBIT $ -430 M
  • EBITDA $ -400 M
  • 60-Month Beta 0.60
  • Price/Sales 2,099.37
  • Price/Cash Flow N/A
  • Price/Book 2.96

Options Overview Details

View History
  • Implied Volatility 72.69% ( +5.48%)
  • Historical Volatility 76.59%
  • IV Percentile 4%
  • IV Rank 12.48%
  • IV High 320.56% on 08/07/24
  • IV Low 37.36% on 08/15/24
  • Put/Call Vol Ratio 0.08
  • Today's Volume 11,798
  • Volume Avg (30-Day) 18,543
  • Put/Call OI Ratio 0.27
  • Today's Open Interest 227,948
  • Open Int (30-Day) 226,883

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.27
  • Number of Estimates 7
  • High Estimate -0.20
  • Low Estimate -0.33
  • Prior Year -0.45
  • Growth Rate Est. (year over year) +40.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.98 +3.26%
on 11/21/24
12.51 -34.11%
on 11/07/24
-1.68 (-16.94%)
since 10/21/24
3-Month
7.98 +3.26%
on 11/21/24
12.51 -34.11%
on 11/07/24
-3.59 (-30.35%)
since 08/21/24
52-Week
5.24 +57.25%
on 11/22/23
18.33 -55.05%
on 02/28/24
+3.07 (+59.38%)
since 11/21/23

Most Recent Stories

More News
2 Top Biotech Stocks to Buy Now and Hold For 5 Years or More

Biotechs often need several years to realize their visions, even after they have a drug approved for the first time. There's typically plenty of upside in store for enterprising and patient investors.

CRSP : 46.29 (-2.05%)
IOVA : 8.24 (+1.23%)
VRTX : 450.37 (-0.19%)
Biotech Companies’ Q3 Updates: Promising Cancer Treatments on the Horizon

USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – As many biotech companies within the oncology space begin to roll...

ONCY : 0.9800 (-1.85%)
IOVA : 8.24 (+1.23%)
SNDX : 15.60 (-2.19%)
ONC.TO : 1.37 (-2.14%)
IBRX : 5.03 (+3.28%)
SWTX : 36.30 (-3.04%)
Biotech Companies' Q3 Updates: Promising Cancer Treatments on the Horizon

/CNW/ -- USA News Group News Commentary – As many biotech companies within the oncology space begin to roll out their end-of-quarter results, the American...

ONCY : 0.9800 (-1.85%)
IOVA : 8.24 (+1.23%)
SNDX : 15.60 (-2.19%)
ONC.TO : 1.37 (-2.14%)
IBRX : 5.03 (+3.28%)
SWTX : 36.30 (-3.04%)
Iovance Biotherapeutics: Q3 Earnings Snapshot

Iovance Biotherapeutics: Q3 Earnings Snapshot

IOVA : 8.24 (+1.23%)
Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Third Quarter and Year to Date 2024

IOVA : 8.24 (+1.23%)
Iovance Biotherapeutics to Host Third Quarter and Year-to-Date 2024 Financial Results Conference Call and Webcast on Thursday, November 7, 2024

IOVA : 8.24 (+1.23%)
Why Iovance Biotherapeutics Stock Triumphed on Thursday

With a cutting-edge melanoma drug now on the market, the company is positioned for a breakout.

IOVA : 8.24 (+1.23%)
UBS : 31.74 (-0.28%)
Is Iovance Biotherapeutics Stock a Buy?

The biotech is making important breakthroughs, but is that enough?

IOVA : 8.24 (+1.23%)
3 Reasons to Buy Iovance Biotherapeutics Stock Like There's No Tomorrow

This biotech's growth story is going to start moving faster, and soon.

IOVA : 8.24 (+1.23%)
3 Things You Need to Know if You Buy Iovance Biotherapeutics Today

There's plenty of upside with this stock, but it might take a while to realize.

IOVA : 8.24 (+1.23%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Iovance Biotherapeutics is a clinical-stage pharmaceutical company primarily focused on the development and commercialization of novel T cell-based cancer immunotherapies. These immunotherapies use Generation 2 ('Gen 2') tumor infiltrating lymphocyte (TIL), which harnesses the power of a patient's own...

See More

Key Turning Points

3rd Resistance Point 8.82
2nd Resistance Point 8.60
1st Resistance Point 8.42
Last Price 8.24
1st Support Level 8.02
2nd Support Level 7.80
3rd Support Level 7.62

See More

52-Week High 18.33
Fibonacci 61.8% 13.33
Fibonacci 50% 11.78
Fibonacci 38.2% 10.24
Last Price 8.24
52-Week Low 5.24

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar